Skip to content
Open access

The OPRM1 A118G G Allele Is Associated With Poorer Auditory-Verbal Learning and Memory, Executive Functions, and Working Memory in Veterans Undergoing Residential Treatment for Alcohol Use Disorder.

Aug 2026 · Alcohol, clinical & experimental research · Vol 50 8, pp. e70385 · 0 citations · 43 references
Medicine

TL;DR

It is suggested that altered MOR signaling in G-allele carriers may be associated with differences in prefrontal network efficiency, potentially justifying future studies investigating the relationship between OPRM1 and glutamatergic plasticity.

Abstract

Background

The neurocognitive dysfunction observed in Alcohol Use Disorder (AUD) is related to a complex interplay between genetic, neurobiological, and environmental factors. The μ-opioid receptor (MOR), encoded by the OPRM1 gene, modulates reward processing, stress responsivity, and excitatory-inhibitory activity within prefrontal-limbic and hippocampal circuits implicated in neurocognition. The common A118G (Asn40Asp, rs1799971) polymorphism alters MOR expression and signaling, but its contribution to domain-specific cognitive functioning in AUD, particularly among Veterans, has received limited investigation.

Methods

Veterans (n = 127) in residential treatment for AUD completed a neurocognitive battery assessing the following domains of functioning: auditory-verbal and visuospatial learning and memory, executive function, and working memory. Participants were genotyped for OPRM1 A118G, and A homozygotes and G-allele carriers (AG/GG) were compared on the above measures, using bootstrapped generalized linear models, adjusted for age, education, biological sex, race, pre-study alcohol consumption, and brain-derived neurotrophic factor (BDNF) (rs6265) and catechol-O-methyltransferase (COMT) (rs4680) genotypes, which have been previously shown to be associated with neurocognition.

Results

G-allele carriers demonstrated significantly worse performance than A homozygotes on measures of auditory-verbal learning and memory, cognitive flexibility/set shifting, auditory working memory, and on a composite average of all measures. BDNF or COMT genotypes were not associated with any measure, and there were no significant interactions among OPRM1, BDNF, and COMT genotypes.

Conclusions

Findings suggest that altered MOR signaling in G-allele carriers may be associated with differences in prefrontal network efficiency, potentially justifying future studies investigating the relationship between OPRM1 and glutamatergic plasticity. The results highlight a potential genetically influenced contributor to the neurocognitive heterogeneity in AUD and underscore the possible value of integrating MOR-related biological markers into neurocognitive assessment of individuals with AUD.

Read PDF

Similar papers

Open access Sep 2026

577. **Rafaelsen Award Presentation** Association between cortical serotonin release and cognitive function in schizophrenia: an in vivo [11C]Cimbi-36 PET study with a d-Amphetamine challenge

This is the first direct assessment of the relationship between serotonin release and cognition in schizophrenia and shows that neocortical serotonin release is directly associated with general intellectual function in schizophrenia.

M. Osugo, T. R. Marques, M. Veronese et al. · 0 citations
Review Aug 2026

Social Cognition as an Under-Used Behavioural Endpoint in Neurodevelopmental Psychopharmacology: A Conditional Framework for Integrating Theory of Mind into Clinical Trial Design.

Social cognition, encompassing theory of mind (ToM), facial affect recognition, and mentalising under social load, is impaired across several neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), developmental language disorder (DLD), and intelle...

Berkan Şahi̇n · 0 citations
Open access Sep 2026

Executive function in alcohol use disorder with low psychiatric comorbidity: Comparison with a non-clinical sample and predictive value for treatment outcome

Investigating the degree of impairment and predictive ability of EF, on alcohol consumption, among individuals with moderate AUD with low levels of psychiatric comorbidity found EFs were not impaired and were not a clinically relevant predictor of treatment outcomes in this population with AUD.

S. Ingesson-Hammarberg, M. Garke, L. Khemiri et al. · 0 citations
Open access Sep 2026

fNIRS-based neurofeedback targeting the right dorsolateral prefrontal cortex (dlPFC) in children at familial risk for substance use disorder and/or severe mental illness: a proof-of-concept study from eastern India

Background Children who have first-degree relatives diagnosed with substance use disorders and/or severe mental illnesses show altered prefrontal cortical development and an elevated risk of executive function impairment. fNIRS-based neurofeedback (NF) is a portable, child-tolerant technique for the modulation of corti...

Titli Saha, Poulami Giri, Rajnita Nag et al. · 0 citations
Open access Aug 2026

The molecular and neurochemical basis of altered intrinsic neural timescales in major depressive disorder: a multimodal imaging-transcriptomic investigation of esketamine and sertraline treatment

A multiscale pathophysiological framework involving brain connectivity dynamics, molecular architecture, and neurochemical regulation in patients with MDD is supported, suggesting a role for inhibitory neurotransmission in temporal integration deficits.

Xiang Liu, Yuanzhi He, Li-Feng Li et al. · 0 citations
Open access Sep 2026

543. Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities

This study is the first to demonstrate how prefrontal–striatal hypoconnectivity and altered striatal DAT markers are associated with different domains of cognitive impairment in schizophrenia.

Y.-H. Chou, K.-C. Yang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.